Kinetic and mechanistic studies of the interaction of 2-mercapto pyridine with dichloro[1-alkyl-2-(arylazo)imidazole]palladium(II) complexes

Nucleophilic substitution of Pd(RaaiR′)Cl₂ [(RaaiR′ = 1-alkyl-2-(arylazo)imidazole, p-R-C₆H₄-N=N-C₃H₂NN-1-R′; where R = H(a)/ Me(b)/ Cl(c) and R′ = Et(1)/Bz(2)] with 2-Mercaptopyridine (2-SH-Py) in acetonitrile (MeCN) at 298 K, to form [Pd₂(2-S-Py)₄], has been studied spectrophotometrically under pseudo-first-order conditions and the analyses support the nucleophilic association path. The reaction follows the rate law, Rate = {k ₀ + k [2-SH-Py] ₀ ² }[Pd(RaaiR′)Cl₂]: first order in Pd(RaaiR′)Cl₂ and second order in 2-SH-Py. The rate of the reaction follows the order: Pd(RaaiEt)Cl₂ (1) < Pd(RaaiBz)Cl₂ (2) and Pd(MeaaiR′)Cl₂ (b) < Pd(HaaiR′)Cl₂ (a) < Pd(ClaaiR′)Cl₂ (c). External addition of Cl⁻ (LiCl) and HCl suppresses the rate (Rate ∝ 1/[Cl⁻]₀ & ∝1/[HCl]₀). The reactions have been studied at different temperatures (293–308 K) and activation parameters (Δ^‡ H° and Δ ^‡ S°) of the reactions were calculated from the Eyring plot and support the proposed mechanism.     

Efficacious and sustained release of an anticancer drug mitoxantrone from new covalent organic frameworks using protein corona

Solid porous and crystalline covalent organic frameworks (COFs) are characterized by their higher specific BET surface areas and functional pore walls, which allow the adsorption of various bioactive molecules inside the porous lattices. We have introduced a perylene-based COF, PER@PDA-COF-1, which acts as an effective porous volumetric reservoir for an anticancer drug, mitoxantrone (MXT). The drug-loaded COF (MXT–PER@PDA-COF-1) exhibited zero cellular release of MXT towards cancer cells, which can be attributed to the strong intercalation between the anthracene-dione motif of the drug and the perylene-based COF backbone. Here, we have introduced a strategy involving the serum-albumin-triggered intracellular release of mitoxantrone from MXT–PER@PDA-COF-1. The serum albumin acts as an exfoliating agent and as a colloidal stabilizer in PBS medium (pH = 7.4), rapidly forming a protein corona around the exfoliated COF crystallites and inducing the sustained release of MXT from the COF into tumorigenic cells.

Solid porous and crystalline covalent organic frameworks (COFs) are characterized by their higher specific BET surface areas and functional pore walls, which allow the adsorption of various bioactive molecules inside the porous lattices.     

A terahertz polarization insensitive dual band metamaterial absorber

Metamaterial absorbers have attracted considerable attention for applications in the terahertz range. In this Letter, we report the design, fabrication, and characterization of a terahertz dual band metamaterial absorber that shows two distinct absorption peaks with high absorption. By manipulating the periodic patterned structures as well as the dielectric layer thickness of the metal-dielectric-metal structure, significantly high absorption can be obtained at specific resonance frequencies. Finite-difference time-domain modeling is used to design the structure of the absorber. The fabricated devices have been characterized using a Fourier transform IR spectrometer. The experimental results show two distinct absorption peaks at 2.7 and 5.2?THz, which are in good agreement with the simulation. The absorption magnitudes at 2.7 and 5.2?THz are 0.68 and 0.74, respectively.     

Characteristics of in-out intermittency in delay-coupled FitzHugh–Nagumo oscillators

We analyze a pair of delay-coupled FitzHugh–Nagumo oscillators exhibiting in-out intermittency as a part of the generating mechanism of extreme events. We study in detail the characteristics of in-out intermittency and identify the invariant subsets involved – a saddle fixed point and a saddle periodic orbit – neither of which are chaotic as in the previously reported cases of in-out intermittency. Based on the analysis of a periodic attractor possessing in-out dynamics, we can characterize the approach to the invariant synchronization manifold and the spiralling out to the saddle periodic orbit with subsequent ejection from the manifold. Due to the striking similarities, this analysis of in-out dynamics also explains in-out intermittency     

η4‐HBCC‐σ,π‐Borataallyl Complexes of Ruthenium Comprising an Agostic Interaction

Thermolysis of [Cp*Ru(PPh₂(CH₂)PPh₂)BH₂(L₂)] 1 (Cp*=η⁵‐C₅Me₅; L=C₇H₄NS₂), with terminal alkynes led to the formation of η⁴‐σ,π‐borataallyl complexes [Cp*Ru(μ‐H)B{R‐C=CH₂}(L)₂] ( 2 a – c ) and η²‐vinylborane complexes [Cp*Ru(R‐C=CH₂)BH(L)₂] ( 3 a – c ) ( 2 a , 3 a : R=Ph; 2 b , 3 b : R=COOCH₃; 2 c , 3 c : R=p‐CH₃‐C₆H₄; L=C₇H₄NS₂) through hydroboration reaction. Ruthenium and the HBCC unit of the vinylborane moiety in 2 a – c are linked by a unique η⁴‐interaction. Conversions of 1 into 3 a – c proceed through the formation of intermediates 2 a – c . Furthermore, in an attempt to expand the library of these novel complexes, chemistry of σ‐borane complex [Cp*RuCO(μ‐H)BH₂L] 4 (L=C₇H₄NS₂) was investigated with both internal and terminal alkynes. Interestingly, under photolytic conditions, 4 reacts with methyl propiolate to generate the η⁴‐σ,π‐borataallyl complexes [Cp*Ru(μ‐H)BH{R‐C=CH₂}(L)] 5 and [Cp*Ru(μ‐H)BH{HC=CH‐R}(L)] 6 (R=COOCH₃; L=C₇H₄NS₂) by Markovnikov and anti‐Markovnikov hydroboration. In an extension, photolysis of 4 in the presence of dimethyl acetylenedicarboxylate yielded η⁴‐σ,π‐borataallyl complex [Cp*Ru(μ‐H)BH{R‐C=CH‐R}(L)] 7 (R=COOCH₃; L=C₇H₄NS₂). An agostic interaction was also found to be present in 2 a – c and 5 – 7 , which is rare among the borataallyl complexes. All the new compounds have been characterized in solution by IR, ¹H, ¹¹B, ¹³C NMR spectroscopy, mass spectrometry and the structural types were unequivocally established by crystallographic analysis of 2 b , 3 a – c and 5 – 7 . DFT calculations were performed to evaluate possible bonding and electronic structures of the new compounds.